Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-07-10

Clinical Trial Update: Detecting the Impact of Statin Therapy On Lowering Risk of Venous Thrombo-Embolic Events (DISOLVE) [Phase 2]

View source ↗

Summary

A Phase 2 trial (DISOLVE) completed evaluating whether statin therapy lowers the risk of venous thromboembolism and deep vein thrombosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Statin therapy (statin)

Snippet

Sponsor: University of Vermont | Conditions: Venous Thromboembolism, Deep Vein Thrombosis | Phase 2 | Status: COMPLETED